MRSA Infection Clinical Trial
Official title:
The Efficacy of SinoFresh Nasal and Sinus Care Nasal Spray in Eliminating MRSA From the Nasal Cavity
| Verified date | May 2016 |
| Source | University of Chicago |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | United States: Institutional Review Board |
| Study type | Interventional |
This is a study to assess the ability of SinoFresh Nasal & Sinus Care, an FDA approved over-the-counter nasal spray, to eliminate the bacteria in your nose.
| Status | Withdrawn |
| Enrollment | 0 |
| Est. completion date | June 2013 |
| Est. primary completion date | June 2010 |
| Accepts healthy volunteers | No |
| Gender | Both |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: - 18 years or older - The volunteer is able to adhere to the study requirements and study visits. - Agrees to abstain from use of other nasal sprays for length of study. - Diagnosis of an MRSA carrier by PCR testing Exclusion Criteria: - History of chronic nose bleeds. - History of intranasal steroids in the last 2 months - Nasal obstruction severe enough to prohibit effective delivery of a nasal spray - Epistaxis - Significant excoriation in the opinion of the Investigator. - Known hypersensitivity to any ingredients |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment
| Country | Name | City | State |
|---|---|---|---|
| United States | The University of Chicago | Chicago | Illinois |
| Lead Sponsor | Collaborator |
|---|---|
| University of Chicago |
United States,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | This is a study to assess the ability of SinoFresh Nasal & Sinus Care, an FDA approved over-the-counter nasal spray, to eliminate the bacteria in your nose. | 7 days | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00448942 -
The Impact of Chlorhexidine-Based Bathing on Nosocomial Infections
|
N/A | |
| Completed |
NCT00685867 -
Two Strategies for Methicillin-resistant Staphylococcus Aureus (MRSA) Infection Prevention in Surgical Patients
|
N/A | |
| Withdrawn |
NCT00766259 -
Relationship of Staphylococcal Colonization to Infection
|
||
| Completed |
NCT00731783 -
Staphylococcus Aureus Decolonization Study
|
N/A | |
| Completed |
NCT00711854 -
Randomized Clinical Trial to Compare a Regimen of Trimethoprim-sulfamethoxazole Plus Rifampicin With a Regimen of Linezolid in the Treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA) Infection
|
Phase 4 | |
| Not yet recruiting |
NCT01724671 -
Vancomycin Versus Ceftaroline in Patients With Infections Caused by MRSA That Are Susceptible to Ceftaroline
|
N/A | |
| Recruiting |
NCT00502476 -
Multicenter Trial of Daily Chlorhexidine Bathing to Reduce Nosocomial Infections
|
N/A | |
| Completed |
NCT01814371 -
Individualized vs. Household MRSA Decolonization
|
N/A |